knowledge -WSS

knowledge

author：focus 2025-10-01 17:05:48 - browse：7

This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox.

Hello, friends! I’m in San Francisco for the STAT Breakthrough Summit. Later today, I’ll be “fireside chatting” with Cytokinetics CEO Robert Blum. It’s not too late to join us virtually. Check out details here.

It’s a travel-shortened week for me, so in this newsletter, I decided to dive deep into PDS Biotech and its experimental drug for head and neck cancer. PDS is what I’d call a biotech cult stock.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Medicare bonuses could stop drug shortages under Senate plan

WSS

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

Medicare drug price lawsuits could be good politics for Biden

Pumping milk in bathrooms at health conferences is common

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Crowdfunding for unproven stem cell procedures spreads misinformation

To bolster infectious disease surveillance, genomics powerhouses team up

focus

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

Cancer drug shortages should be causing more outrage

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Medical leaders decry Supreme Court decision on affirmative action

Head of FDA's diagnostics center, who led through Covid, retires

Medical leaders decry Supreme Court decision on affirmative action

Mass General, Mayo Clinic look to monetize custom

资本理应停止对独角兽的膜拜，让每个努力的公司都能得到橄榄枝。

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Heart attack and stroke risk calculators need revising

Skip the lead apron during X

explore

Hubble vs. James Webb telescope images: See the difference

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

Skip the lead apron during X

Hubble vs. James Webb telescope images: See the difference

Canadians with cystic fibrosis outlive Americans by a decade

explore

Wikipedia

entertainment

hotspot